Search Results 1031-1040 of 19346 for Hemoglobin

1. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

   Anemia is required for trial entry (defined as hemoglobin < 10g/dL or transfusion dependent [having needed a transfusion anytime in the past 6 months]) ...

2. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL. Hemoglobin = ______;; Total bilirubin < 1.5 x upper limit of normal (ULN), or < 2.5 x ULN if patient has Gilbert syndrome or ...

3. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

   Hemoglobin ≤ 11 g/dL; Hyperviscosity syndrome or measured viscosity level of ≥ 4 centipoise. NOTE: for these patients it is strongly recommended that they ...

4. A Study to Evaluate the Safety and Effectiveness of Felzartamab in IgA Nephropathy - Mayo Clinic

   Participation eligibility · Glycated hemoglobin (HbA1c) < 8.0% or < 64 mmoL/mol.; · No diabetic retinopathy known; · No peripheral neuropathy known.

5. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   Hemoglobin or hematocrit <75% of the lower limit of normal range; Serum AST and/or ALT > 3 times the upper limit of normal range'; Pregnancy (including family ...

6. A Study To Assess Effectiveness And Safety Of Octreotide Subcutaneous Depot In Patients With Acromegaly - Mayo Clinic

   Patients with poorly controlled diabetes mellitus (hemoglobin A1c > 8.0%). Participating Mayo Clinic locations. Study statuses change often. Please contact ...

7. Eligibility and FAQs - Mayo Clinic

   Brief health checkup. Before you give blood, a healthcare professional checks your temperature, blood pressure and pulse and does a hemoglobin test to make sure ...

8. High-Dose Radiation Therapy Versus Standard Care in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl (NOTE: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable); Cancer antigen 19-9 (CA19 ...

9. Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer - Mayo Clinic

   Patients with hemoglobin less than 10 g/dL (to minimize the impact of potential iatrogenic anemia). Participating Mayo Clinic locations. Study statuses change ...

10. Transforming stomach cancer care: 6 recent innovations - Mayo Clinic

    Other outcomes, including weight loss and hemoglobin levels, also were favorable." 4. Immunotherapy with, and possibly in place of, surgery. Immunotherapy is ...